3.31 USD
↘ 0.14 (3.94%)LIVE (AS OF 01:59 PM EST)
Prelude Therapeutics Incorporated (PRLD) trades at $3.31 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. PRLD is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.